Genetic syndromes and congenital heart defects: how is surgical management affected?

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 4, 2009, Pages 606-614

  Formigari, Roberto ^a   Michielon, Guido ^b   Digilio, Maria Cristina ^b   Piacentini, Gerardo ^c   Carotti, Adriano ^b   Giardini, Alessandro ^a   Di Donato, Roberto M ^b   Marino, Bruno ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Congenital heart disease; Genetic syndromes; Genotype phenotype correlation

Indexed keywords

CHROMOSOME DELETION; CHROMOSOME DELETION 22Q11; CLINICAL PROTOCOL; CONGENITAL HEART MALFORMATION; GENETIC DISORDER; HUMAN; LEOPARD SYNDROME; MARFAN SYNDROME; NOONAN SYNDROME; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL RISK; TRISOMY 13; TRISOMY 18; TRISOMY 21; TURNER SYNDROME; WILLIAMS BEUREN SYNDROME;

GENETIC DISEASES, INBORN; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; PHENOTYPE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; SYNDROME;

EID: 62149141331     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.11.005     Document Type: Review

References (156)

1. Ferencz C., Loffredo C.A., Correa-Villasenor A., and Magee C.A. Categorization of cardiovascular malformations for risk factor analysis. In: Ferencz C., Loffredo C.A., Correa-Villasenor A., and Wilson P.D. (Eds). Genetic and environmental risk factors of major cardiovascular malformation: the Baltimore-Washington study 1981-1989 (1997), Futura, Armonk, NY 13-28
2. Eskedal L., Hagemo P., Eskild A., Aamodt G., Seiler K.S., and Thaulow E. A population-based study of extra-cardiac anomalies in children with congenital cardiac malformations. Cardiol Young 14 (2004) 600-607
3. Eskedal L.T., Hagemo P.S., Eskild A., Froslie K.F., Seiler S., and Thaulow E. A population-based study relevant to seasonal variations in causes of death in children undergoing surgery for congenital cardiac malformations. Cardiol Young 17 (2007) 423-431
4. Cleves M.A., Ghaffar S., Zhao W., Mosley B.S., and Hobbs C.A. First-year survival of infants born with CHD in Arkansas (1993-1998): a survival analysis using registry data. Birth Defect Res (Part A) 67 (2003) 662-668
5. Pritchard M.A., and Kola I. The 'gene dosage effect' hypothesis versus the 'amplified developmental instability' hypothesis in Down syndrome. J Neural Transm 57 (1999) 293-303
6. Marino B., and Digilio M.C. Congenital heart disease and genetic syndromes: specific correlation between cardiac phenotype and genotype. Cardiovasc Pathol 9 (2000) 303-315
7. De Biase L., Di Ciommo V., Ballerini L., Bevilacqua M., Marcelletti C., and Marino B. Prevalence of left-sided obstructive lesions in patients with atrioventricular canal without Down's syndrome. J Thorac Cardiovasc Surg 91 (1986) 467-469
8. Goldmuntz E., Clark B.J., Mitchell L.E., Jawad A.F., Cuneo B.F., Reed L., McDonald-McGinn D., Chien P., Feuer J., Zackai E.H., Emanuel B.S., and Driscoll D.A. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 32 (1998) 492-498
9. Wren C., Oslizlok P., and Bull C. Natural history of supravalvular aortic stenosis and pulmonary artery stenosis. J Am Coll Cardiol 15 (1990) 1625-1630
10. Bonnet D., Pelet A., Legeai-Mallet L., Sidi D., Mathieu M., Parent P., Plauchu H., Serville F., Schinzel A., and Weissenbach J. A gene for Holt--Oram syndrome maps to the distal long arm of chromosome 12. Nat Genet 6 (1994) 405-408
11. Digilio M.C., Marino B., Ammirati A., Borzaga U., Giannotti A., and Dallapiccola B. Cardiac malformations in patients with oral-facial-skeletal syndrome: clinical similarities with heterotaxia. Am J Genet 84 (1999) 350-356
12. Oosterhof T., Nollen G.J., van der Wall E.E., Spijkerboer A.M., Hrudova J., Bouma B.J., Dijkgraaf M.G., and Mulder B.J. Comparison of aortic stiffness in patients with juvenile forms of ascending aortic dilatation with versus without Marfan's syndrome. Am J Cardiol 95 (2005) 996-998
13. Marino B., Digilio M.C., Toscano A., Giannotti A., and Dallapiccola B. Congenital heart disease in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 136 (1999) 703-706
14. Prandstraller D., Mazzanti L., Picchio F.M., Magnani C., Bergamaschi R., Perri A., Tsingos E., and Cacciari E. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-up of 136 non-preselected patients. Pediatr Cardiol 20 (1999) 108-112
15. Jongewaard I.N., Lauer R.M., Behrendt D.A., Patil S., and Klewer S.E. Beta 1 integrin activation mediates adhesive differences between trisomy 21 and non-trisomic fibroblasts on type VI collagen. Am J Med Genet 109 (2002) 298-305
16. Cleves M.A., Hobbs C.A., Cleves P.A., Tilford J.M., Bird T.M., and Robbins J.M. Congenital defect among liveborn infants with Down syndrome. Birth Defects Res A Clin Mol Teratol 79 (2007) 657-663
17. Marino B. Left-sided cardiac obstruction in patients with Down syndrome. J Pediatr 115 (1989) 834-835
18. Carmi R., Boughman J.A., and Ferencz C. Endocardial cushion defect: further studies of "isolated" versus "syndromic" occurrence. Am J Med Genet 43 (1992) 569-575
19. Giamberti A., Marino B., Di Carlo D., Iorio F.S., Formigari R., de Zorzi A., and Marcelletti C. Partial atrioventricular canal with congestive heart failure in the first year of life: surgical options. Ann Thorac Surg 62 (1996) 151-156
20. Manning P.B., Mayer J.E., Sanders S.P., Coleman E.A., Jonas R.A., Keane J.F., VanPraagh S., and Castañeda A.R. Unique features and prognosis of primum ASD presenting in the first year of life. Circulation 90 Suppl. 2 (1994) 30-35
21. Lacour Gayet F., Bonnet N., Piot D., Serraf A., Sousa-Uva M., Belli E., Roussin R., Bruniaux J., and Planché C. Surgical management of atrioventricular septal defects with normal karyotype. Eur J Cardiothorac Surg 11 (1997) 466-472
22. Al-Hay A.A., MacNeill S.J., Yacoub M., Shore D.F., and Shinebourne E.A. Complete atrioventricular septal defect, Down syndrome, and surgical outcome: risk factors. Ann Thorac Surg 75 (2003) 412-421
23. Formigari R., Di Donato R.M., Gargiulo G., Di Carlo D., Feltri C., Picchio F.M., and Marino B. Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome. Ann Thorac Surg 78 (2004) 666-672
24. Lange R., Guenther T., Busch R., Hess J., and Schreiber C. The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg 134 (2007) 304-310
25. Vet T.W., and Ottenkamp J. Correction of atrioventricular septal defect. Results influenced by Down syndrome?. Am J Dis Child 143 (1989) 1361-1365
26. Weintraub R.G., Brawn W.J., Venables A.W., and Mee R.B. Two-patch repair of complete atrioventricular septal defect in the first year of life. Results and sequential assessment of atrioventricular valve function. J Thorac Cardiovasc Surg 99 (1990) 320-326
27. Rizzoli G., Mazzucco A., Maizza F., Daliento L., Rubino M., Tursi V., and Scalia D. Does Down syndrome affect prognosis of surgically managed atrioventricular canal defects?. J Thorac Cardiovasc Surg 104 (1992) 945-953
28. Di Carlo D., and Marino B. Atrioventricular canal with Down syndrome or normal chromosomes: distinct prognosis with surgical management?. J Thorac Cardiovasc Surg 107 (1994) 1368-1370
29. Bull C., Rigby M.L., and Shinebourne E.A. Should management of complete atrioventricular canal defect be influenced by coexistent Down syndrome?. Lancet 14 (1985) 1147-1149
30. Marino B. Valve insufficiency after atrioventricular septal defect repair: differences between patients with and without Down's syndrome?. Ann Thorac Surg 5 (1990) 854
31. Masuda M., Kado H., Tanoue Y., Fukae K., Onzuka T., Shiokawa Y., Shirota T., and Yasui H. Does Down syndrome affect the long-term results of complete atrioventricular septal defect when the defect is repaired during the first year of life?. Eur J Cardiothorac Surg 27 (2005) 405-409
32. Welke K.F., Morris C.D., King E., Komanapalli C., Reller M.D., and Ungerleider R.M. Population-based perspective of long-term outcomes after surgical repair of partial atrioventricular septal defect. Ann Thorac Surg 84 (2007) 624-629
33. Knott-Craig C.J., Elkins R.C., Ramakrishnan K., Hartnett D.A., Lane M.M., Overholt E.D., Ward K.E., and Razook J.R. Associated atrial septal defects increase perioperative morbidity after ventricular septal defect repair in infancy. Ann Thorac Surg 59 (1995) 573-578
34. Marino B., Papa M., Guccione P., Corno A., Marasini M., and Calabro R. Ventricular septal defect in Down syndrome. Am J Dis Child 144 (1990) 544-545
35. Mulder T.J., Pyles L.A., Stolfi A., Pickoff A.S., and Moller J.H. A multicenter analysis of the choice of initial surgical procedure in tetralogy of Fallot. Pediatr Cardiol 23 (2002) 580-586
36. Anaclerio S., Di Ciommo V., Michielon G., Digilio M.C., Formigari R., Picchio F.M., Gargiulo G., Di Donato R., De Ioris M.A., and Marino B. Conotruncal heart defects: impact of genetic syndromes on immediate operative mortality. Ital Heart J 5 (2004) 1-5
37. Michielon G., Marino B., Formigari R., Gargiulo G., Picchio F., Digilio M.C., Anaclerio S., Oricchio G., Sanders S.P., and Di Donato R.M. Genetic syndromes and outcome after surgical correction of tetralogy of Fallot. Ann Thor Surg 81 (2006) 968-975
38. Fiore A.C., Turrentine M., Rodefeld M., Vijay P., Schwartz T.L., Virgo K.S., Fischer L.K., and Brown J.W. Fontan operation: a comparison of lateral tunnel with extracardiac conduit. Ann Thorac Surg 83 (2007) 622-630
39. Jacobs M.L., Pelletier G.J., Pourmoghadam K.K., Mesia C.I., Madan N., Stern H., Schwartz R., and Murphy J.D. Protocols associated with no mortality in 100 consecutive Fontan procedures. Eur J Cardiothorac Surg 33 (2008) 626-632
40. Banks M.A., Jenson J., and Kugler J.D. Late development of atrioventricular block after congenital heart surgery in Down syndrome. Am J Cardiol 88 A7 (2001) 86-89
41. Tucker E.M., Pyles L.A., Bass J.L., and Moller J.H. Permanent pacemaker for atrioventricular conduction block after operative repair of perimembranous ventricular septal defects. J Am Coll Cardiol 50 (2007) 1196-1200
42. Rasmussen S.A., Wong L.Y., Correa A., Gambrell D., and Friedman J.M. Survival in infants with Down syndrome, Metropolitan Atlanta, 1979-1998. J Pediatr 148 (2006) 806-812
43. Di Carlo D., and Marino B. Patient selection for repair of complete atrioventricular canal guided by echocardiography. J Am Coll Cardiol 26 (1995) 574
44. Silberbach M., Shumaker D., Menashe V., Cobanoglu A., and Morris C. Predicting hospital charge and length of stay for congenital heart disease surgery. Am J Cardiol 72 (1993) 958
45. Roussot M.A., Lawrenson J.B., Hewitson J., Smart R., and De Decker H.P. Is cardiac surgery warranted in children with Down syndrome? A case-controlled review. S Afr Med J 96 (2006) 924-930
46. Rowland T.W., Nodstrom L.G., Bean M.S., and Burkhardt H. Chronic upper airway obstruction and pulmonary hypertension in Down's syndrome. Am J Dis Child 135 (1981) 1050-1052
47. Ugazio A.G., Lanzavecchia A., Jayakar S., Plebani A., Duse M., and Burgio G.R. Immunodeficiency in Down's syndrome. Acta Paediatr Scand 67 (1978) 705-708
48. Kohel M., Creighton R.E., and Steward D.J. Anaesthetic consideration in Down's syndrome: experience with 100 patients and review of the literature. Can Anaesth Soc J 29 (1982) 593-599
49. Morrey J.P., Mac Gillivray R., and Duker G. Increased perioperative risk following repair of congenital heart disease in Down's syndrome. Anaesthesiology 65 (1986) 221-224
50. Katlic M.R., Clark E.B., Neill C., and Haller Jr. J.A. Surgical management of congenital heart disease in Down's syndrome. J Thorac Cardiovasc Surg 74 (1977) 204-209
51. Journois D., Baufreton C., Mauriat P., Pouard P., Vouhé P., and Safran D. Effects of inhaled nitric oxide administration on early postoperative mortality in patients operated for correction of atrioventricular canal defects. Chest 128 (2005) 3537-3544
52. Hilton J.M., Fitzgerald D.A., and Cooper D.M. Respiratory morbidity of hospitalized children with trisomy 21. J Paediatr Child Health 35 (1999) 383-386
53. Botto L.D., May K., Fernhoff P.M., Correa A., Coleman K., Rasmussen S.A., Merrit R.K., O'Leary L.A., Wong L.Y., Elixson E.M., Mahle W.T., and Campbell R.M. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112 (2003) 101-107
54. Shprintzen R.J. Velo-cardio-facial syndrome: 30 years of study. Dev Disabil Res Rev 14 (2008) 3-10
55. McDonald-McGinn D.M., Kirschner R., Goldmuntz E., Sullivan K., Eicher P., Gerdes M., Moss E., Solot C., Wang P., Jacobs I., Handler S., Knightly C., Heher K., Wilson M., Ming J.E., Grace K., Driscoll D., Pasquariello P., Randall P., Larossa D., Emanuel B.S., and Zackai E.H. The Philadelphia story. The 22q11. 2 deletion: report on 250 patients. Genet Couns 10 (1999) 11-24
56. Lindsay E.A., Vitelli F., Su H., Morishima M., Huynh T., Pramparo T., Jurecic V., Ogunrinu G., Sutherland H.F., Scambler P.J., Bradley A., and Baldini A. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410 (2001) 97-101
57. Marino B., Digilio M.C., Grazioli S., Formigari R., Mingarelli R., Giannotti A., and Dallapiccola B. Associated cardiac anomalies in isolated and syndromic patients with tetralogy of Fallot. Am J Cardiol 77 (1996) 505-508
58. Momma K., Kondo C., Ando M., Matsuoka R., and Takao A. Tetralogy of Fallot associated with chromosome 22q11 deletion. Am J Cardiol 76 (1995) 618-621
59. Johnson M.C., Strass A.W., Dowton S.B., Spray T.L., Huddleston C.B., Wood M.K., Slaugh R.A., and Watson M.S. Deletion within chromosome 22 is common in patients with absent pulmonary valve syndrome. Am J Cardiol 76 (1995) 66-69
60. Maeda J., Yamagishi H., Matsuoka R., Ishihara J., Tokumura M., Fukushima H., Ueda H., Takahashi E., Yoshiba S., and Kojima Y. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet 92 (2000) 269-272
61. Digilio M.C., Marino B., Grazioli S., Agostino D., Giannotti A., and Dallapiccola B. Comparison of occurrence of genetic syndrome in ventricular septal defect with pulmonic stenosis (classic tetralogy of Fallot) versus ventricular septal defect with pulmonic atresia. Am J Cardiol 77 (1996) 1375-1376
62. Momma K., Kondo C., and Matsuoka R. Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion. J Am Coll Cardiol 27 (1996) 198-202
63. Chessa M., Butera G., Bonhoeffer P., Iserin L., Kachaner J., Lyonnet S., Munnich A., Sidi D., and Bonnet D. Relation of genotype 22q11 deletion to phenotype of pulmonary vessels in tetralogy of Fallot and pulmonary atresia-ventricular septal defect. Heart 79 (1998) 186-190
64. Hofbeck M., Rauch A., Buheitel G., Leipold G., von der Emde J., Pfeiffer R., and Singer H. Monosomy 22q11 in patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries. Heart 79 (1998) 180-185
65. Ackerman M.J., Wylam M.E., Feldt R.H., Porter C.J., Dewald G., Scanlon P.D., and Driscoll D.J. Pulmonary atresia with ventricular septal defect and persistent airway hyperresponsiveness. J Thorac Cardiovasc Surg 122 (2001) 169-177
66. Deerojanawong J., Chang A.B., Eng P.A., Robertson C.F., and Kemp A.S. Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome. Pediatr Pulmonol 24 (1997) 324-330
67. Carotti A., Marino B., and Di Donato R.M. Influence of chromosome 22q11.2 microdeletion on surgical outcome after treatment of tetralogy of Fallot with pulmonary atresia. J Thorac Cardiovasc Surg 126 (2003) 1666-1667
68. Mahle W.T., Cristalli J., Coleman K., Campbell R.M., Tam V.K., Vincent R.N., and Kanter K.R. Deletion of chromosome 22q11.2 and outcome in patients with pulmonary atresia and ventricular septal defect. Ann Thorac Surg 76 (2003) 567-571
69. Ishibashi N., Shin'oka T., Ishiyama M., Sakamoto T., and Kurosawa H. Clinical results of staged repair with complete unifocalization for pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. Eur J Cardiothorac Surg 32 (2007) 202-208
70. Carotti A., Digilio M.C., Piacentini G., Saffirio C., Di Donato R.M., and Marino B. Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. Dev Disabil Res Rev 14 (2008) 35-42
71. Momma K., Ando M., and Matsuoka R. Truncus arteriosus communis associated with chromosome 22q11 deletion. J Am Coll Cardiol 30 (1997) 1067-1071
72. Marino B., Digilio M.C., and Toscano A. Common arterial trunk, DiGeorge syndrome and microdeletion 22q11. Prog Pediatr Cardiol 15 (2002) 9-17
73. Williams J.M., de Leeuw M., Black M.D., Freedom R.M., Williams W.G., and McCrindle B.W. Factors associated with outcomes of persistent truncus arteriosus. J Am Coll Cardiol 34 (1999) 545-553
74. Schreiber C., Eicken A., Balling G., Wottke M., Schumacher G., Un Paek S., Meisner H., Hess J., and Lange R. Single centre experience on primary correction of common arterial trunk: overall survival and freedom from reoperation after more than 15 years. Eur J Cardiothorac Surg 18 (2000) 68-73
75. Marino B., Digilio M.C., Persiani M., Di Donato R., Toscano A., Giannotti A., and Dallapiccola B. Deletion 22q11 in patients with interrupted aortic arch. Am J Cardiol 84 (1999) 360-361
76. Oosterhof T., Azakie A., Freedom R.M., Williams W.G., and McCrindle B.W. Associated factors and trends in outcomes of interrupted aortic arch. Ann Thorac Surg 78 (2004) 1696-1702
77. McCrindle B.W., Tchervenkov C.I., Konstantinov I.E., Williams W.G., Neirotti R.A., Jacobs M.L., Blackstone E.H., and Congenital Heart Surgeons Society. Risk factors associated with mortality and interventions in 472 neonates with interrupted aortic arch: a Congenital Heart Surgeons Society Study. J Thorac Cardiovasc Surg 129 (2005) 343-350
78. Michielon G., Oricchio G., Marino B., Gargiulo G., Picchio F., Digilio M.C., Anaclerio S., Oricchio G., Sanders S.P., and Di Donato R.M. Impact of genetic syndromes on surgical outcome of conotruncal heart defect. Circulation 114 18 (2006) II.695
79. Jatana V., Gillis J., Webster B.H., and Adès L.C. Deletion 22q11.2 syndrome - implications for the intensive care physician. Pediatr Crit Care Med 8 (2007) 459-463
80. Shashi V., Berry M.N., and Hines M.H. Vasomotor instability in neonates with chromosome 22q11 deletion syndrome. Am J Med Genet 121 (2003) 231-234
81. McElhinney D.B., Jacobs I., McDonald-McGinn D.M., Zackai E.H., and Goldmuntz E. Chromosomal and cardiovascular anomalies associated with congenital laryngeal web. Int J Pediatr Otorhinolaryngol 66 (2002) 23-27
82. Kyburz A., Bauersfeld U., Schinzel A., Riegel M., Hug M., Tomaske M., and Valsangiacomo Buchel ER. The fate of children with microdeletion 22q11. 2 syndrome and congenital heart defect: clinical course and cardiac outcome. Pediatr Cardiol 29 (2008) 76-83
83. Atallah J., Joffe A.R., Robertson C.M., Leonard N., Blakley P.M., Nettel-Aguirre A., Sauve R.S., Ross D.B., and Rebeyka I.M. Two-year general and neurodevelopmental outcome after neonatal complex cardiac surgery in patients with deletion 22q11.2: a comparative study. J Thorac Cardiovasc Surg 134 (2007) 772-779
84. Zeltser I., Jarvik G.P., Bernbaum J., Wernovsky G., Nord A.S., Gerdes M., Zackai E., Clancy R., Nicolson S.C., Spray T.L., and Gaynor J.W. Genetic factors are important determinants of neurodevelopmental outcome after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 135 (2008) 91-97
85. Maharasingam M., Ostman-Smith I., and Pike M.G. A cohort study of neurodevelopmental outcome in children with DiGeorge syndrome following cardiac surgery. Arch Dis Child 88 (2003) 61-64
86. Gerdes M., Solot C., Wang P.P., Moss E., LaRossa D., Randall P., Goldmuntz E., Clark Jr. B.J., Driscoll D.A., Jawad A., Emanuel B.S., McDonald-McGinn D.M., Batshaw M.L., and Zackai E.H. Cognitive and behaviour profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 85 (1999) 127-133
87. Tartaglia M., Kalidas K., Shaw A., Song X., Musat D.L., van der Burgt I., Brunner H.G., Bertola D.R., Crosby A., Ion A., Kucherlapati R.S., Jeffery S., Patton M.A., and Gelb B.D. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype, phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70 (2002) 1555-1563
88. Digilio M.C., Conti E., Sarkozy A., Mingarelli R., Dottorini T., Marino B., Pizzuti A., and Dallapiccola B. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71 (2002) 389-394
89. Sarkozy A., Conti E., Seripa D., Digilio M.C., Grifone N., Tandoi C., Fazio V.M., Di Ciommo V., Marino B., Pizzuti A., and Dallapiccola B. Correlation between PTPN11 gene mutations and CHDs in Noonan and LEOPARD syndromes. J Med Genet 40 (2003) 704-708
90. Noonan J.A. Noonan syndrome and related disorders. Prog Pediatr Cardiol 20 (2005) 177-185
91. Yoshida R., Hasegawa T., Hasegawa Y., Nagai T., Kinoshita E., Tanaka Y., Kanegane H., Ohyama K., Onishi T., Hanew K., Okuyama T., Horikawa R., Tanaka T., and Ogata T. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome. J Clin Endocrinol Metab 89 (2004) 3359-3364
92. Limongelli G., Pacileo G., Marino B., Digilio M.C., Sarkozy A., Elliott P., Versacci P., Calabro P., De Zorzi A., Di Salvo G., Syrris P., Patton M., McKenna W.J., Dallapiccola B., and Calabro R. Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 100 (2007) 736-741
93. Colan S.D., Lipshultz S.E., Lowe A.M., Sleeper L.A., Messere J., Cox G.F., Lurie P.R., Orav E.J., and Towbin J.A. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Finding from the pediatric cardiomyopathy registry. Circulation 115 (2007) 776-781
94. Tartaglia M., Pennacchio L.A., Zhao C., Yadav K.K., Fodale V., Sarkozy A., Pandit B., Oishi K., Martinelli S., Schackwitz W., Ustaszewska A., Martin J., Bristow J., Carta C., Lepri F., Neri C., Vasta I., Gibson K., Curry C.J., Siguero J.P., Digilio M.C., Zampino G., Dallapiccola B., Bar-Sagi D., and Gelb B.D. Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome. Nat Genet 39 (2007) 75-79
95. Pandit B., Sarkozy A., Pennacchio L.A., Carta C., Oishi K., Martinelli S., Pogna E.A., Schackwitz W., Ustaszewska A., Landstrom A., Bos J.M., Ommen S.R., Esposito G., Lepri F., Faul C., Mundel P., Lopez Siguero J.P., Tenconi R., Selicorni A., Rossi C., Mazzanti L., Torrente I., Marino B., Digilio M.C., Zampino G., Ackerman M.J., Dallapiccola B., Tartaglia M., and Gelb B.D. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39 (2007) 1007-1012
96. Gotzsche C.O., Krag-Olsen B., Nielsen J., Sorensen K.E., and Kristensen B.O. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 71 (1994) 433-436
97. Brandt B., Heintz S.E., Rose E.F., Herenhaft J.L., and Clark E.B. Repair of coarctation of the aorta in children with Turner syndrome. Pediatr Cardiol 5 (1985) 175-179
98. Ravelo H.R., Stephenson L.W., Friedman S., Chatten J., Rashkind W.J., Vidas M., and Edmunds L.H. Coarctation resection in children with Turner's syndrome. A note of caution. J Thorac Cardiovasc Surg 80 (1980) 427-430
99. Fejzic Z., and van Oort A. Fatal dissection of the descending aorta after implantation of a stent in a 19-year-old female with Turner's syndrome. Cardiol Young 15 (2005) 529-531
100. Reis P.M., Punch M.R., Bove E.L., and Van de Ven C.J.M. Outcome of infants with hypoplastic left heart syndrome and Turner syndromes. Obstet Gynecol 93 (1999) 532-535
101. Jacobs M.L., Blackstone E.H., and Bailey L.L. Intermediate survival in neonates with aortic atresia: a multi-institutional study. J Thorac Cardiovasc Surg 116 (1998) 417-431
102. Gaynor J.W., Mahle W.T., Cohen M.I., Ittenbach R.F., DeCampli W.M., Steven J.M., Nicolson S.C., and Spray T.L. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg 22 (2002) 82-89
103. Lin A.E., Lippe B., and Rosenfeld R.G. Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics 102 (1998) e12
104. Sachdev V., Matura L.A., Sidenko S., Ho V.B., Arai A.E., Rosine D.R., and Bondy C.A. Aortic valve disease in Turner syndrome. J Am Coll Cardiol 51 (2008) 1904-1909
105. Beauchesne L.M., Connolly H.M., Ammash N.M., and Warnes C.A. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol 38 (2001) 1728-1733
106. The Practice Committee of the American Society for Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil Steril 2005;83:1074-5.
107. Carlson M., and Silberbach M. Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature. J Med Genet 44 (2007) 745-749
108. Matura L.A., Ho V.B., Rosing D.R., and Bondy C.A. Aortic dilatation and dissection in Turner syndrome. Circulation 116 (2007) 1663-1670
109. Baguet J.P., Douchin S., Pierre H., Rossignol A.M., Bost M., and Mallion J.M. Structural and functional abnormalities of large arteries in the Turner syndrome. Heart 91 (2005) 1442-1446
110. Ostberg J.E., Donald A.E., Halcox P.J., Storry C., McCarthy C., and Conway G.S. Vasculopathy in Turner syndrome: arterial dilatation and intimal thickening without endothelial dysfunction. J Clin Endocrinol Metab 90 (2005) 5161-5166
111. Gravholt C.H., Landin-Wilhelmsen K., Stochholm K., Hjerrild B.E., Ledet T., Djurhuus C.B., Sylven L., Baandrup U., Kristensen B.O., and Christiansen J.S. Clinical and epidemiological description of aortic dissection in Turner syndrome. Cardiol Young 16 (2006) 430-436
112. Gravholt C.H., Hansen K.W., Erlandsen M., Ebbehøj E., and Christiansen J.S. Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 24 (2006) 353-360
113. Dietz H.C., Cutting G.R., and Pyeritz R.E. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 (1991) 337-339
114. Gersony D.R., McClaughlin M.A., Jin Z., and Gersony W.M. The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis. Int J Cardiol 114 (2007) 303-308
115. Yetman A.T., Bornemeier R.A., and McCrindle B.W. Usefulness of enalapril versus propanolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol 95 (2005) 1125-1127
116. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., Myers L., Klein E.C., Liu G., Calvi C., Podowski M., Neptune E.R., Halushka M.K., Bedja D., Gabrielson K., Rifkin D.B., Carta L., Ramirez F., Huso D.L., and Dietz H.C. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312 (2006) 117-121
117. Lacro R.V., Dietz H.C., Wruck L.M., Bradley T.J., Colan S.D., Devereux R.B., Klein G.L., Li J.S., Minich L.L., Paridon S.M., Pearson G.D., Printz B.F., Pyeritz R.E., Radojewski E., Roman M.J., Saul J.P., Stylianou M.P., and Mahony L. Rationale and design of a randomized clinical trial of β-blocker therapy (atenonol) versus angiotensin II receptor block therapy (losartan) in individuals with Marfan syndrome. Am Heart J 154 (2007) 624-631
118. Williams A., Davies S., Stuart A.G., Wilson D.G., and Fraser A.G. Medical treatment of Marfan syndrome: a time for change. Heart 94 (2008) 414-421
119. Ahimatos A.A., Aggarwal A., D'Orsa K.M., Formosa M.F., White A.J., Savarirayan R., Dart A.M., and Kingwell B.A. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome. JAMA 298 (2007) 1539-1547
120. Brooke B.S., Habashi J.P., Judge D.P., Patel N., Loeys B., and Dietz III H.C. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358 (2008) 2787-2795
121. Yetman A.T., Bonemeier R.A., and McCrindle B.W. Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?. J Am Coll Cardiol 41 (2003) 329-332
122. Januzzi J.L., Marayati F., Mehta R.H., Cooper J.V., O'Gara P.T., Sechtem U., Bossone E., Evangelista A., Oh J.K., Nienaber C.A., Eagle K.A., and Isselbacher E.M. Comparison of aortic dissection in patients with and without Marfan's syndrome (results from the international registry of aortic dissection). Am J Cardiol 94 (2004) 400-402
123. Carrel T., Berdat P., Pavlovic M., Sukhanov S., Englberger L., and Pfammatter J.P. Surgery of the dilated aortic root and ascending aorta in pediatric patients: techniques and results. Eur J Cardiothorac Surg 24 (2003) 249-254
124. Bethea B.T., Fitton T.P., Alejo D.E., Barreiro C.J., Cattaneo S.M., Dietz H.C., Spevak P.J., Lima J.A., Gott V.L., and Cameron D.E. Results of aortic valve-sparing operations: experience with remodeling and reimplantation. Ann Thorac Surg 78 (2004) 767-772
125. Meijboom L.J., Timmermans J., Zwinderman A.H., Engelfriet P.M., and Mulder B.J. Aortic root growth in men and women with the Marfan syndrome. Am J Cardiol 96 (2005) 1441-1444
126. de Oliveira N.C., David T.E., Ivanov J., Armstrong S., Eriksson M.J., Rakowski H., and Webb G. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg 125 (2003) 789-796
127. Abdel-Massih T., Goldberg A., Vouhé P., Iserin F., Acar P., Villain E., Agnoletti G., Sidi D., and Bonnet D. Marfan syndrome in the newborn and infants less than 4 months: a series of 9 patients. Arch Mal Coeur Vaiss 95 (2002) 469-472
128. Abdel-Massih T., Vouhé P.R., Mauriat P., Mousseaux E., Sidi D., and Bonnet D. Replacement of the ascending aorta in children: a series of fourteen patients. J Thorac Cardiovasc Surg 124 (2002) 411-413
129. Knosalla C., Weng Y., Hammerschmidt R., Pasic M., Schmitt-Knosalla I., Grauhan O., Dandel M., Lehmkuhl H.B., and Hetzer R. Othotopic heart transplantation in patients with Marfan syndrome. Ann Thorac Surg 83 (2007) 1691-1696
130. Ammash N.M., Sundt T.M., and Connolly H.M. Marfan syndrome - diagnosis and management. Curr Probl Cardiol 33 (2008) 7-39
131. Ewart A.K., Morris C.A., Atkinson D., Jin W., Sternes K., Spallone P., Stock A.D., Leppert M., and Keating M.T. Hemizygosity at the elastin locus in developmental disorder, Williams syndrome. Nat Genet 5 (1993) 11-16
132. Dridi S.M., Foucault Bertaud A., Igondjo Tchen S., Senni K., Ejeil A.L., Pellat B., Lyonnet S., Bonnet D., Charpiot P., and Godeau G. Vascular wall remodeling in patients with supravalvular aortic stenosis and Williams Beuren syndrome. J Vasc Res 42 (2005) 190-201
133. Stamm C., Friehs I., Ho S.Y., Moran A.M., Jonas R.A., and del Nido P.J. Congenital supravalvular aortic stenosis: a simple lesion?. Eur J Cardiothorac Surg 19 (2001) 195-202
134. Brown J.W., Ruzmetov M., Vijay P., and Turrentine M.W. Surgical repair of congenital supravalvular aortic stenosis in children. Eur J Cardiothorac Surg 21 (2002) 50-56
135. Geggel R.L., Gavreau K., and Lock J.E. Balloon dilation angioplasty of peripheral pulmonary stenosis associated with Williams syndrome. Circulation 103 (2001) 2165-2170
136. Horowitz P.E., Akhtar S., Wulff J.A., Al Fadley F., and Al Halees Z. Coronary artery disease and anesthesia-related death in children with Williams syndrome. J Cardiothorac Vasc Anesth 16 (2002) 739-741
137. Medley J., Russo P., and Tobias J.D. Perioperative care of patients with Williams syndrome. Paediatr Anaesth 15 (2005) 243-247
138. Giordano U., Turchetta A., Giannotti A., Digilio M.C., Virgilii F., and Calzolari A. Exercise testing and 24-hour ambulatory blood pressure monitoring in children with Williams syndrome. Pediatr Cardiol 22 (2001) 509-511
139. Aggoun Y., Sidi D., Levy B.I., Lyonnet S., Kachaner J., and Bonnet D. Mechanical properties of the common carotid artery in Williams syndrome. Heart 84 (2000) 290-293
140. Verrengia M., Pacileo G., Limongelli G., Di Salvo G., Rea A., Iacomino M., Di Simone A., Russo M.G., and Calabrò R. Left ventricle myocardial mechanics and textural properties in patients with Williams syndrome. J Cardiovasc Med 8 (2007) 330-336
141. Bird L.M., Billman G.F., Lacro R.V., Spicer R.L., Jariwala L.K., Hoyme H.E., Zamora-Salinas R., Morris C., Viskochil D., Frikke M.J., and Jones M.C. Sudden death in Williams syndrome: report of ten cases. J Pediatr 129 (1996) 926-931
142. Bonnet D., Cormier V., Villain E., Bonhoeffer P., and Kachaner J. Progressive left main coronary artery obstruction leading to myocardial infarction in a child with Williams syndrome. Eur J Pediatr 156 (1997) 751-753
143. van Pelt N.C., Wilson N.J., and Lear G. Severe coronary artery disease in the absence of supravalvular stenosis in a patient with Williams syndrome. Pediatr Cardiol 26 (2005) 665-667
144. Graham E.M., Bradley S.M., Shirali G.S., Hills C.B., Atz A.M., and Pediatric Cardiac Care Consortium. Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 93 (2004) 801-803
145. Blue G.M., Mah J.M., Cole A.D., Lal V., Wilson M.J., Chard R.B., Sholler G.F., Hawker R.E., Sherwood M.C., and Winlaw D.S. The negative impact of Alagille syndrome on survival of infants with pulmonary atresia. J Thorac Cardiovasc Surg 133 (2007) 1094-1096
146. Komajda M., and Charron P. How will the human genome project change cardiovascular medicine?. Heart 86 (2001) 123-124
147. Pleger S.T., and Koch W.J. Translational medicine in genetic familial diseases: from the autopsy room to the molecular bench and vice versa. Hum Pathol 36 (2005) 708-709
148. Ashrafian H., and Watkins H. Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications. J Am Coll Cardiol 49 (2007) 1251-1264
149. Schwartz P.J., Priori S.G., Locati E.H., Napolitano C., Cantu F., Towbin J.A., Keating M.T., Hammoude H., Brown A.M., and Chen L.S. Long QT syndrome patients with mutations of the SNC5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy. Circulation 92 (1995) 2381-2386
150. Clark E.B. Pathogenetic mechanisms of congenital cardiovascular malformations revisited. Semin Perinatol 20 (1996) 465-472
151. Schneider D.S., Zahka K.G., Clark E.B., and Neill C.A. Patterns of cardiac care in infants with Down syndrome. Am J Dis Child 143 (1989) 363-365
152. Truesdell S.C., and Clark E.B. Health insurance status in a cohort of children and young adults with congenital cardiac diagnoses. Circulation 84 (1991) II-386
153. Pastore E., Marino B., Calzolari A., Digilio M.C., Giannotti A., and Turchetta A. Clinical and cardiorespiratory assessment in children with Down syndrome without congenital heart disease. Arch Ped Adoles 154 (2000) 408-410
154. Russo M.G., Pacileo G., Marino B., Pisacane C., Calabrò P., Ammirati A., and Calabrò R. Echocardiographic evaluation of left ventricular systolic function in the Down syndrome. Am J Cardiol 81 (1998) 1215-1217
155. Robinson W.M., and Newburger J.W. Ethical issues concerning cardiac surgery in patients with syndromic abnormalities. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 6 (2003) 147-151
156. Pierpont M.E., Basson C.T., Benson Jr. D.W., Gelb B.D., Giglia T.M., Goldmuntz E., McGee G., Sable C.A., Srivastava D., and Webb C.L. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115 (2007) 3015-3038